Articles published by Spectrum Pharmaceuticals, Inc.
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces Management Changes
January 04, 2023
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff
December 27, 2022
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 10, 2022
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals to Report Third Quarter 2022 Financial Results and Provide Corporate Update
November 03, 2022
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON™ (eflapegrastim-xnst) Injection
September 09, 2022
Via Business Wire
Tickers
SPPI
Via Business Wire
Tickers
SPPI
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for Eflapegrastim
April 11, 2022
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces Poster Presentation at the Upcoming AACR Annual Meeting
April 04, 2022
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical
January 04, 2022
Via Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors
December 01, 2021
Via Business Wire
Tickers
SPPI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.